S
Sharad Goyal
Researcher at Rutgers University
Publications - 129
Citations - 2163
Sharad Goyal is an academic researcher from Rutgers University. The author has contributed to research in topics: Breast cancer & Radiation therapy. The author has an hindex of 23, co-authored 116 publications receiving 1850 citations. Previous affiliations of Sharad Goyal include University of Virginia & Robert Wood Johnson University Hospital.
Papers
More filters
Journal ArticleDOI
Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms
TL;DR: The pathophysiology of cardiac disease related to radiation therapy to the chest, including myocardial fibrosis and cardiomyopathy, coronary artery disease, valvular disease, pericardial disease, and arrhythmias is reviewed.
Journal ArticleDOI
Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy.
Chirag Shah,Shahed N. Badiyan,Sameer Berry,Atif J. Khan,Sharad Goyal,Kevin Schulte,Anish Nanavati,Melanie Lynch,Frank A. Vicini +8 more
TL;DR: Evaluated cardiac dose sparing techniques in breast cancer radiotherapy showed promise dosimetrically and may use surrogates for cardiac events such as biomarkers or perfusion imaging and future studies are required to validate the efficacy of cardiac doses sparing techniques.
Journal ArticleDOI
Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor
TL;DR: It is concluded that EGF stimulates RTE cell proliferation and maturation and reduces apoptosis in the neonatal rat kidney subjected to chronic UUO, and may contribute to the reduction in tubular dilation, tubular atrophy, and interstitial fibrosis.
Journal ArticleDOI
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
Sachin R. Jhawar,Aditya Thandoni,Praveen K. Bommareddy,Suemair Hassan,Frederick J. Kohlhapp,Sharad Goyal,Jason M. Schenkel,Ann W. Silk,Andrew Zloza +8 more
TL;DR: The natural characteristics and genetically engineered modifications that enhance the effectiveness of oncolytic viruses for the treatment of cancer are reviewed.
Journal ArticleDOI
Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients
Sibo Tian,Kim M. Hirshfield,Salma K. Jabbour,Deborah Toppmeyer,Bruce G. Haffty,Atif J. Khan,Sharad Goyal +6 more
TL;DR: Clinical evidence that supports the use of established biomarkers such as cardiac troponins and natriuretic peptides, as well as emerging data on proposed biomarkers are reviewed.